Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  glioblastoma cancer vaccine ERC1671
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
ERC1671/GM-CSF/Cyclophosphamide in Treating Patients with Relapsed Glioblastoma Multiforme
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: ERC1671-H02, NCI-2014-00737, 11922, ERC1671, UCI 13-14, NCT01903330
Start Over